» Articles » PMID: 25667621

Increased Adenosine Levels Contribute to Ischemic Kidney Fibrosis in the Unilateral Ureteral Obstruction Model

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2015 Feb 11
PMID 25667621
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Renal interstitial fibrosis (RIF) occurs as a result of chronic kidney disease (CKD) and is a common pathway leading to end-stage renal failure. Renal tissue hypoxia and ischemia are present during CKD. Adenosine (ADO) is an important signaling molecule induced under ischemic and hypoxic conditions. In the present study, the association between ADO and RIF was investigated using a mouse model, with the aim of obtaining important information relevant to the prevention and treatment of RIF. A unilateral ureteral obstruction (UUO) model of RIF was established in mice. A total of 44 male mice were randomly divided into sham, model and intervention groups, and samples were collected on days 1, 3, 7, and 14 after modeling. These were collected to detect hypoxia and changes in ADO concentration in obstructed renal tissue as well as to analyze the pathological changes and degree of RIF in the renal tissue. Changes in the levels of collagen deposition and profibrogenic factors in renal tissues were analyzed following intervention with an ADO receptor blocker. Following the UUO procedure, continuous hypoxia was present in the obstructed renal tissue, accompanied by an increased ADO concentration. Tubular injury and interstitial fibrosis progressively increased over time following the UUO procedure. The mRNA expression levels of tissue tumor growth factor β (TGF-β) and α(I) procollagen were significantly increased. Subsequent to the ADO pathway being blocked by 8-(-sulfophenyl)-theophylline, tubular injury and interstitial fibrosis were reduced and the expression of related cytokines was decreased. Increased ADO levels were induced by hypoxia, causing the development of RIF. Following the blocking of the ADO pathway, renal damage was deferred and renal functions were protected.

Citing Articles

3D autofluorescence imaging of hydronephrosis and renal anatomical structure using cryo-micro-optical sectioning tomography.

Fan G, Jiang C, Huang Z, Tian M, Pan H, Cao Y Theranostics. 2023; 13(14):4885-4904.

PMID: 37771780 PMC: 10526660. DOI: 10.7150/thno.86695.


Shen Qi Wan-Containing Serum Alleviates Renal Interstitial Fibrosis via Restraining Notch1-Mediated Epithelial-Mesenchymal Transition.

Chen H, Zhou X, Yang Y, Feng Y Evid Based Complement Alternat Med. 2023; 2023:3352353.

PMID: 36793762 PMC: 9925256. DOI: 10.1155/2023/3352353.


Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.

Pak E, Cha J, Cha D, Kanasaki K, Ha H Kidney Res Clin Pract. 2022; 41(Suppl 2):S74-S88.

PMID: 36239063 PMC: 9590297. DOI: 10.23876/j.krcp.22.011.


Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy.

Li Y, Tian Z, Pan G, Zhao P, Pan D, Zhang J Front Pharmacol. 2022; 13:977284.

PMID: 36160409 PMC: 9503832. DOI: 10.3389/fphar.2022.977284.


Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis.

Liu L, Ning X, Wei L, Zhou Y, Zhao L, Ma F Theranostics. 2022; 12(8):3758-3775.

PMID: 35664054 PMC: 9131259. DOI: 10.7150/thno.71722.


References
1.
Liu Y . Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69(2):213-7. DOI: 10.1038/sj.ki.5000054. View

2.
Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M . Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol. 2004; 172(6 Pt 1):2456-9. DOI: 10.1097/01.ju.0000138473.38447.f0. View

3.
Eltzschig H, Thompson L, Karhausen J, Cotta R, Ibla J, Robson S . Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood. 2004; 104(13):3986-92. DOI: 10.1182/blood-2004-06-2066. View

4.
Fredholm B . Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007; 14(7):1315-23. DOI: 10.1038/sj.cdd.4402132. View

5.
Hewitson T . Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol. 2009; 296(6):F1239-44. DOI: 10.1152/ajprenal.90521.2008. View